Imidazole derivatives for treatment of allergic and hyperproliferative disorders

Details for Australian Patent Application No. 2004229466 (hide)

Owner Avanir Pharmaceuticals

Inventors Sircar, Jagadish C.; Thomas, Richard J.; Khatuya, Haripada; Richards, Mark L.

Agent Davies Collison Cave

Pub. Number AU-A-2004229466

PCT Pub. Number WO2004/091610

Priority 60/462,090 10.04.03 US

Filing date 9 April 2004

Wipo publication date 28 October 2004

International Classifications

A61K 031/4164 - 1,3-Diazoles

C07D 233/00 Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

A61P 035/00 Antineoplastic agents

A61P 037/08 Drugs for immunological or allergic disorders

A61P 011/06 Drugs for disorders of the respiratory system

Event Publications

20 October 2005 PCT application entered the National Phase

  PCT publication WO2004/091610 Priority application(s): WO2004/091610

13 December 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004229467-Lysophosphatidic acid analogs and inhibition of neointima formation

2004229465-Compositions and methods related to production of erythropoietin